Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices.
Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS. Shaded region = analyst consensus for the current and next fiscal year (26 analysts).
| Parameter | BaseValue |
|---|---|
Initial Cash Flow | |
| Growth Rate (Yr 1-5) | % |
| Growth Rate (Yr 6-10) | % |
| Terminal Growth Rate | % |
| Discount Rate | % |
Base Case $89.49 Implied EV: $181.97B |
What growth rate is the market pricing in at $102?
The market implies +12.0% Owner Earnings growth, above historical trends.
Standard FCF implies a demanding +12.4%, reflecting heavy growth investment.
Wide moat with strength across all dimensions. Margin Stability is the standout factor.
"Market is pessimistic — investigate whether fears are temporary or structural"
Near fair value with balanced sentiment — no strong signal in either direction
